Crocs, Inc.
NASDAQ:CROXApparel - Footwear & Accessories
+$1.47 today
- Market cap
- $7.44B
- Beta
- 1.56
- P/E (TTM)
- -61.1
- EPS (TTM)
- -$2.06
Volume 0.90M
Average 1.25M
CROX Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Crocs, Inc.NASDAQ: CROX
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue declines year over year
Q3 FY2026 cost of revenue of $352.85M fell 14.6% year over year, behind the -0.1% change in trailing-twelve-month cost of revenue. Sequentially, it fell 26.3% from the prior quarter. Over 3 fiscal years it compounded at -0.2% a year.
Context
- Cost of revenue amounted to 41.7% of revenue in FY2025, up 0.4 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -14.6% toward the trailing-twelve-month pace of -0.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 1.68B USD
- Year-over-year change
- -0.5%
- 4-year CAGR
- +17.2%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.68B | -0.5% |
| FY2024 | 2024-12-31 | 1.69B | -5.2% |
| FY2023 | 2023-12-31 | 1.78B | +5.3% |
| FY2022 | 2022-12-31 | 1.69B | +89.7% |
| FY2021 | 2021-12-31 | 893.2M | — |
Cost of Revenue vs competitors
How CROX compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -0.1% is the 10th highest of 11, against a peer median of +4.9%.
- Cost of revenue amounts to 40.6% of revenue for CROX, versus a peer median of 54.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $26.13B USD | -3.1% | -2.9% | 56.9% | |
| LTM Sep 2026 | $2.29B USD | +3.2% | +8.7% | 41.1% | |
| LTM Sep 2026 | $1.66B USD | -0.1% | -0.2% | 40.6% | |
| LTM May 2026 | $1.62B USD | +0.5% | -10.0% | 55.9% | |
| LTM May 2026 | $1.59B USD | +6.9% | -2.2% | 56.5% | |
| LTM Jun 2026 | $1.48B USD | +7.6% | +6.0% | 53.9% | |
| LTM May 2026 | $1.31B USD | +6.0% | +1.6% | 53.7% | |
| LTM Sep 2026 | CHF 1.12B CHF | +3.8% | +27.8% | 33.3% | |
| LTM Jun 2026 | €1.03B EUR | +25.5% | +20.3% | 45.2% | |
| LTM Mar 2026 | $296.59M USD | +8.6% | -10.0% | 60.2% | |
| LTM Mar 2026 | $157.23M USD | +0.2% | -8.9% | 56.9% | |
| Peer median (excluding CROX) | — | +4.9% | -0.3% | 54.9% | |
Competitors are the stored peer set for CROX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.31B | 3.55B | 3.96B | 4.1B | 4.04B |
| Cost of Revenue | 893.2M | 1.69B | 1.78B | 1.69B | 1.68B |
| Gross Profit | 1.42B | 1.86B | 2.18B | 2.41B | 2.36B |
| Gross Margin | 61.4% | 52.3% | 55.0% | 58.8% | 58.3% |
| Research & Development | 13.7M | 18.7M | 21.4M | 25.6M | 29.6M |
| Selling, General & Admin | 715.89M | 929.16M | 1.11B | 1.29B | 1.44B |
| Operating Expenses | 737.16M | 1.01B | 1.13B | 1.39B | 2.21B |
| Depreciation & Amortization | 31.98M | 39.23M | 54.3M | 69.84M | 79.28M |
| EBITDA | 717.47M | 893.9M | 1.09B | 1.09B | 240.55M |
| EBITDA Margin | 31.0% | 25.1% | 27.6% | 26.6% | 6.0% |
| Operating Income | 683.06M | 850.76M | 1.05B | 1.02B | 149.52M |
| Operating Margin | 29.5% | 23.9% | 26.4% | 24.9% | 3.7% |
| Interest Income | 775K | 1.02M | 2.41M | 3.48M | 1.84M |
| Interest Expense | 21.65M | 136.16M | 161.35M | 109.26M | 88.29M |
| Other Income / Expenses | (19.22M) | (132.25M) | (170.2M) | (111.33M) | (76.54M) |
| Income Before Tax | 663.85M | 718.51M | 876.27M | 910.59M | 72.98M |
| Pre-Tax Margin | 28.7% | 20.2% | 22.1% | 22.2% | 1.8% |
| Income Tax Expense | (61.85M) | 178.35M | 83.71M | (39.49M) | 154.18M |
| Net Income | 725.69M | 540.16M | 792.57M | 950.07M | (81.2M) |
| Net Margin | 31.4% | 15.2% | 20.0% | 23.2% | -2.0% |
| EPS (Basic) | 11.62 | 8.82 | 12.91 | 16.00 | (1.50) |
| EPS (Diluted) | 11.39 | 8.71 | 12.79 | 15.88 | (1.50) |
| Weighted Avg Shares | 62.46M | 61.22M | 61.39M | 59.38M | 54.21M |
| Weighted Avg Shares (Diluted) | 63.72M | 62.01M | 61.95M | 59.83M | 54.21M |
Crocs, Inc.
NASDAQ:CROX
Intrinsic Alpha fair value
Locked
Current Price
$162.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.